Cargando…
Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients’ prognosis
Cysteine- rich secretory protein 3 (CRISP3) prognostic significance in prostate cancer (PCA) has generated mixed result. Herein, we investigated and independently validated CRISP3 expression in relation to ERG and PTEN genomic aberrations and clinical outcome. CRISP3 protein expression was examined...
Autores principales: | Al Bashir, Samir, Alshalalfa, Mohammed, Hegazy, Samar A, Dolph, Michael, Donnelly, Bryan, Bismar, Tarek A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975646/ https://www.ncbi.nlm.nih.gov/pubmed/24606912 http://dx.doi.org/10.1186/1756-8722-7-21 |
Ejemplares similares
-
Cysteine-Rich Secretory Protein-3 (CRISP3) Is Strongly Up-Regulated in Prostate Carcinomas with the TMPRSS2-ERG Fusion Gene
por: Ribeiro, Franclim R., et al.
Publicado: (2011) -
Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancer
por: NOH, BYEONG-JOO, et al.
Publicado: (2016) -
ERG Protein Expression Is of Limited Prognostic Value in Men with Localized Prostate Cancer
por: Teng, Liang Hong, et al.
Publicado: (2013) -
Evolutionary analysis of genes coding for Cysteine-RIch Secretory Proteins (CRISPs) in mammals
por: Arévalo, Lena, et al.
Publicado: (2020) -
Cysteine-Rich Secretory Proteins (CRISP) are Key Players in Mammalian Fertilization and Fertility
por: Gonzalez, Soledad N., et al.
Publicado: (2021)